Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Irhythm Technologies Inc (NQ: IRTC )

51.12 USD -0.03 (-0.06%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 30, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 163,019
Open 50.92
Bid (Size) 50.00 (1)
Ask (Size) 52.50 (1)
Prev. Close 51.15
Today's Range 50.92 - 51.83
52wk Range 48.71 - 286.19
Shares Outstanding 29,303,050
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
iRhythm® Technologies to Present at the 41st Annual Canaccord Genuity Global Growth Conference
From GlobeNewswire News Releases
iRhythm Technologies to Report Second Quarter 2021 Financial Results on August 5, 2021
From GlobeNewswire News Releases

Performance

YTD
-77.58%
-77.58%
1 Month
-19.81%
-19.81%
3 Month
-31.96%
-31.96%
6 Month
-71.91%
-71.91%
1 Year
-58.93%
-58.93%

More News

Read More
iRhythm® Technologies Comments on the Centers for Medicare and Medicaid Services 2022 Proposed Medicare Physician Fee Schedule
From GlobeNewswire News Releases
iRhythm® Technologies and the National Association of Managed Care Physicians Partner to Study the Value of Ambulatory Cardiac Monitoring Solutions
From GlobeNewswire News Releases
The Global Electrophysiology Market Is Projected To Reach $10.6 Billion By 2025
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
The Global Electrophysiology Market Is Projected To Reach $10.6 Billion By 2025
From PR Newswire
Noteworthy Monday Option Activity: IRBT, IRTC, STEM
Tags Stocks
From Market News Video
Implied IHI Analyst Target Price: $381
Tags ETFs
From ETF Channel
Noteworthy Wednesday Option Activity: TDC, AXTI, IRTC
Tags Stocks
From Market News Video
Why Did iRhythm Technologies Fall 16% in June?
Tags IRTC Market News
From Motley Fool
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
Tags LYEL CGEM FLXN
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.